Evaluation of Patient Enrollment in Oncology Phase I Clinical Trials

INTRODUCTION. For anticancer drug development, it is crucial that patients participate in early-phase clinical trials. The main aim of this study was to gain insight into the motivations and other variables influencing patients in their decision to participate in phase I oncology trials. MATERIALS A...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: van der Biessen, Diane A.J., Cranendonk, Merlijn A., Schiavon, Gaia, van der Holt, Bronno, Wiemer, Erik A.C., Eskens, Ferry A.L.M., Verweij, Jaap, de Jonge, Maja J.A., Mathijssen, Ron H.J.
Formato: Artigo
Lenguaje:Inglês
Publicado: AlphaMed Press 2013
Materias:
New Drug Development and Clinical Pharmacology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607530/
https://ncbi.nlm.nih.gov/pubmed/23429738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0334
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares